[SLN] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Mar-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 15.57%
YoY- 5.50%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 5,722 3,144 573 0 0 8 0 -
PBT -9,572 -9,870 -6,665 -4,799 -4,894 -3,328 -2,771 22.93%
Tax -1,888 -1,450 1,150 694 550 570 405 -
NP -7,684 -8,420 -5,515 -4,105 -4,344 -2,758 -2,367 21.67%
Tax Rate - - - - - - - -
Total Cost 13,406 11,564 6,088 4,105 4,344 2,766 2,367 33.49%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -134.29 -267.81 -962.39 0.00 0.00 -34,475.00 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.26 -0.29 -0.21 -0.17 -0.19 -0.12 -0.10 17.25%
EPS Diluted -0.26 -0.29 -0.21 -0.17 -0.19 -0.12 -0.10 17.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.